Captopril, one of the earliest ACE inhibitors developed for treating high blood pressure and heart failure, carries a side-effect profile that partly overlaps with other drugs in its class and partly reflects its unique sulfhydryl-containing chemical structure. The most commonly reported side effects include a persistent dry cough, skin rashes, taste disturbances, and drops in blood pressure, particularly after the first dose. Less common but more serious reactions involve kidney impairment, dangerously elevated potassium levels, a sharp drop in white blood cells, and liver damage. Some of these issues are shared by all ACE inhibitors, while others are more closely linked to captopril specifically.
The Cough That Won’t Quit
A dry, persistent, tickling cough is probably the most recognized side effect of captopril and ACE inhibitors as a class. It tends not to show up immediately. Postmarketing surveillance data found that cough occurred “much later” during therapy compared to other reactions like skin rashes, and it was reported more often in non-smokers.1PubMed Central. Postmarketing surveillance of captopril for hypertension Early case reports confirmed the cough could develop even at low doses and was severe enough that most affected patients needed to stop the drug entirely. Women appear to be disproportionately affected.2PubMed. Cough associated with captopril and enalapril
The good news is that the cough resolves quickly once captopril is discontinued, and no lasting lung effects have been documented. The underlying mechanism involves bradykinin, a peptide that ACE normally breaks down. When captopril blocks ACE, bradykinin accumulates in the airways. Animal studies showed that captopril-driven increases in bradykinin cause plasma leakage in the airways and digestive tract, an effect mediated through bradykinin B2 receptors and the subsequent release of substance P from sensory nerve endings.3PubMed. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P That irritation of sensory nerves in the throat and lungs is what triggers the cough reflex.
A large network meta-analysis found that ACE inhibitors as a class caused cough roughly three times more often than angiotensin receptor blockers (ARBs), which lower blood pressure through a different mechanism that does not involve bradykinin buildup.4PubMed Central. Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis If captopril’s cough becomes intolerable, switching to an ARB is the most common clinical solution. A systematic review of ACE inhibitors versus ARBs for essential hypertension confirmed that ACE inhibitors carried a greater cough risk and that patients tended to stay on ARBs longer, partly because of fewer adverse-event-related dropouts.5PubMed. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension
First-Dose Hypotension
A steep drop in blood pressure after the very first dose of captopril can cause dizziness, lightheadedness, or even fainting. This happens because captopril abruptly blocks the renin-angiotensin system, and the body has not yet had time to compensate. Research found that the biggest blood pressure drops occurred in people who already had high levels of renin and angiotensin II circulating in their blood, as well as those with secondary hypertension or very high baseline blood pressure.6PubMed Central. Factors related to first dose hypotensive effect of captopril: prediction and treatment Interestingly, factors you might expect to matter, like age, kidney function, or the specific captopril dose given, did not show a strong link to the severity of that first-dose drop.
In practice, doctors often start captopril at a low dose and recommend taking the first tablet at bedtime so that if blood pressure drops sharply, you are lying down rather than standing. People who are already taking diuretics or who are salt-depleted are at higher risk because their renin-angiotensin system is already activated, making the sudden blockade more dramatic.
Skin Rashes and Taste Changes
Captopril causes skin reactions more often than most other ACE inhibitors. Postmarketing surveillance showed that these rashes, usually a maculopapular pattern of flat and raised red spots, tend to appear early in therapy, often within the first few weeks.7PubMed Central. Postmarketing surveillance of captopril for hypertension They are generally mild and sometimes resolve on their own even if the drug is continued, though in more severe cases the drug needs to be stopped.
Taste disturbances, often described as a metallic taste or a reduced ability to taste food properly, are another side effect linked to captopril. These disturbances have been attributed to captopril’s sulfhydryl group, a sulfur-containing chemical feature that is not shared by most later ACE inhibitors like enalapril or lisinopril.8PubMed. ACE inhibitors in hypertension: assessment of taste and smell function in clinical trials Both rash and taste disturbance are significantly less common with ACE inhibitors that lack this sulfhydryl structure, which is one reason captopril has been gradually replaced by newer alternatives for many patients.9The American Journal of Medicine. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril
Kidney Effects
Captopril’s impact on the kidneys deserves careful attention because the drug can both help and harm renal function depending on the patient’s underlying condition. In people with congestive heart failure, captopril did not reliably improve kidney function. In one study, kidney filtration (measured by creatinine clearance) dropped by more than a quarter in a third of patients, and the declines tracked with lower blood pressure and higher baseline renin activity.10Heart. Effect of captopril on renal function in patients with congestive heart failure Urine output and sodium excretion also fell, the opposite of what you want in heart failure.
The risk is even more acute for people who have narrowed arteries feeding the kidneys, a condition called renal artery stenosis. In patients with a single functioning kidney and renal artery stenosis, captopril caused acute kidney failure. Investigators traced this to salt depletion triggered by increased prostaglandin production: when the body lost too much sodium, kidney function collapsed. The kidney failure could be reversed by replacing salt, even without stopping captopril, and could be prevented with saline infusion.11PubMed. The causal role of salt depletion in acute renal failure due to captopril in hypertensive patients with a single functioning kidney and renal artery stenosis
A case of a patient with pre-existing chronic kidney disease illustrates the speed at which things can go wrong. Within 48 hours of starting captopril at 150 mg daily, a man’s blood pressure fell from 170/110 to 130/80, but he developed severely reduced urine output and his creatinine roughly doubled. After captopril was stopped and a diuretic was given, kidney function returned to baseline within six days.12PubMed Central. Reversible acute on chronic renal failure during captopril treatment The reversibility is reassuring, but the case underscores why kidney function needs to be monitored closely in the first days and weeks of treatment.
Proteinuria, or protein leaking into the urine, is another kidney-related concern. In a study of 81 patients on captopril for at least four months, six developed significant proteinuria. In most cases the proteinuria appeared within the first four months and eventually subsided, sometimes even without stopping the drug. However, two patients developed persistent proteinuria with associated low albumin and high cholesterol, and kidney biopsies showed membranous nephropathy.13JAMA. Proteinuria During Long-term Captopril Therapy
Potassium Buildup
Captopril suppresses aldosterone, the hormone that normally tells your kidneys to hold onto sodium and excrete potassium. When aldosterone drops, the kidneys retain potassium instead.14PubMed. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis For most people with healthy kidneys, this rise in potassium is modest and clinically insignificant. But for people who already have impaired kidney function, who take potassium-sparing diuretics, or who use potassium supplements, the accumulation can push blood potassium to dangerous levels. High potassium, or hyperkalemia, can cause muscle weakness, heart rhythm abnormalities, and at extreme levels, cardiac arrest. Routine blood tests to check potassium are standard practice for anyone on captopril, especially in the early weeks.
Angioedema
Angioedema is the most dangerous acute reaction to captopril. It involves rapid swelling of the lips, tongue, throat, or face, and when the airway is involved it can be life-threatening. Like the cough, angioedema is thought to be driven by bradykinin accumulation. Cases have been reported not only with captopril but across ACE inhibitors, and the risk does not disappear after substituting one ACE inhibitor for another. Because all drugs in this class block the same enzyme and increase bradykinin, someone who develops angioedema on captopril should generally not be switched to a different ACE inhibitor.
Blood Cell Changes
Captopril can cause neutropenia, a dangerous drop in a type of white blood cell that fights bacterial infections. For people with uncomplicated high blood pressure and normal kidneys, this risk is extremely low and no greater than what exists with many other commonly used drugs. The picture changes sharply in patients with kidney dysfunction, especially those who also have a connective tissue disorder like lupus or scleroderma. In that combination, neutropenia becomes a meaningful concern that has to be weighed carefully against the drug’s therapeutic benefits.15JAMA Internal Medicine. Captopril-Associated Neutropenia: Who Is at Risk? Regular blood counts are recommended for high-risk patients in the early months of therapy.
Liver Injury
Liver damage from captopril is rare but well documented. The most characteristic pattern is cholestatic jaundice, where bile flow from the liver is blocked. A review of cases reported to the drug manufacturer and in the medical literature identified 14 cases of hepatic injury linked to captopril. Nine were categorized as purely cholestatic, and most of the rest showed a mixed cholestatic-hepatocellular pattern.16PubMed. Captopril-associated cholestatic jaundice
In one reported case, a patient who had been on captopril 25 mg three times daily for a month developed jaundice, itching, loss of appetite, weight loss, liver enlargement, and abdominal tenderness. Liver biopsy confirmed cholestasis. After captopril was stopped, recovery was slow but complete.17PubMed. Captopril-induced cholestatic jaundice This type of reaction appears to be idiosyncratic, meaning it is unpredictable and not related to the dose. Warning signs to watch for include yellowing of the skin or eyes, dark urine, pale stools, persistent nausea, or unexplained itching.
Pregnancy Risks
Captopril, along with all other ACE inhibitors, is contraindicated in pregnancy. Use during gestation can cause fetal death, poor fetal growth, severely low amniotic fluid, low blood pressure in the newborn, and acute kidney failure in the infant. A case report documented a newborn exposed to captopril in utero who developed acute renal failure and a patent ductus arteriosus shortly after birth.18PubMed. Captopril use in pregnancy and its effects on the fetus and the newborn: case report The dangers are most pronounced in the second and third trimesters, when the fetal kidneys are developing and depend heavily on the renin-angiotensin system. Women of childbearing age prescribed captopril should use reliable contraception, and the drug should be stopped as soon as pregnancy is confirmed.
Interaction With Anti-Inflammatory Painkillers
A common and underappreciated interaction occurs between captopril and nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Research on the combined use of captopril and ibuprofen showed that the two drugs have opposing effects on how the kidneys handle sodium and water. Captopril increases sodium and water excretion, while ibuprofen decreases it. When both are taken together, ibuprofen blunts captopril’s kidney effects.19PubMed. Interaction of captopril and ibuprofen on glomerular and tubular function in humans In practical terms, this means regular NSAID use can reduce captopril’s blood-pressure-lowering effect and worsen fluid retention. For people taking captopril for heart failure, where getting rid of excess fluid is critical, this interaction is especially relevant. Occasional use of ibuprofen for a headache is unlikely to cause problems, but chronic NSAID use alongside captopril warrants a conversation with your doctor about alternatives like acetaminophen.
How Captopril Compares to Newer ACE Inhibitors
Captopril was the first ACE inhibitor approved for clinical use, and its side-effect profile partly reflects its era. The drug’s sulfhydryl group is responsible for several adverse effects, including rash, taste disturbance, neutropenia, and proteinuria, that are seen less often with later ACE inhibitors such as enalapril, which lacks this chemical feature. Direct safety comparisons between captopril and enalapril concluded that enalapril was generally better tolerated, with fewer sulfhydryl-related adverse effects.20The American Journal of Medicine. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril Another comparison noted that while both drugs had few adverse effects overall, the incidences differed in ways that suggested a link to chemical structure.21The American Journal of Medicine. Angiotensin converting enzyme inhibitors in congestive heart failure: Overview in comparison of captopril and enalapril
Class-wide side effects, by contrast, follow you to any ACE inhibitor. The cough, angioedema, first-dose hypotension, potassium elevation, and kidney effects are all driven by the mechanism of ACE inhibition itself, not by captopril’s unique structure. Switching from captopril to lisinopril or ramipril will relieve the rash and taste problems, but not the cough or the risk of angioedema. If those class-wide effects are the issue, the usual alternative is an ARB.
Why Some People React Differently
Not everyone responds to captopril in the same way, and genetics plays a role. A study examining variants in the ACE2 gene found that women carrying a particular genetic variant (the T allele) had a reduced blood pressure response to captopril, with an adjusted diastolic blood pressure drop about 3.3 mm Hg less than women without the variant.22PubMed. Polymorphisms of ACE2 gene are associated with essential hypertension and antihypertensive effects of Captopril in women A weaker blood pressure response could mean dose adjustments, more frequent monitoring, or earlier consideration of an alternative drug. Pharmacogenomic testing for ACE inhibitor response is not yet routine, but research like this hints at a future where prescribing could be more individualized.
Beyond genetics, several practical factors influence who gets side effects and how severe they are. People with already compromised kidneys, those on diuretics that deplete sodium, patients with autoimmune conditions, and individuals taking potassium supplements or potassium-sparing diuretics all face amplified risks. Age alone did not predict the first-dose blood pressure drop in the studies that investigated it, but the combination of age with dehydration or heavy diuretic use can create a riskier scenario.
Monitoring That Matters
Because captopril’s most serious side effects involve the kidneys, blood cells, electrolytes, and liver, your doctor will typically order a set of baseline blood tests before starting the drug and repeat them periodically. Kidney function and potassium are usually checked within the first week or two of treatment, and again after any dose increase. For people with autoimmune disease or pre-existing kidney problems, white blood cell counts are monitored more frequently during the first few months. Liver enzymes may be checked if symptoms of jaundice or abdominal discomfort appear.
One practical detail worth knowing: captopril is best absorbed on an empty stomach, taken about an hour before meals. Food reduces its absorption substantially. Because of its short duration of action compared to newer ACE inhibitors, captopril is usually dosed two or three times a day, which can be less convenient. That dosing frequency, combined with the sulfhydryl-related side effects, is a major reason newer ACE inhibitors have largely replaced captopril for everyday blood pressure management. Captopril still sees use in specific situations, such as hypertensive urgency where its rapid onset is useful, or in settings where its long track record and low cost make it the most practical choice.